Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
- ByBenzinga-
The FDA granted accelerated approval to Incyte Corporation's (NASDAQ: INCY) Zynyz (retifanlimab-dlwr) for adult patients with metastatic or recurrent locally advanced Merkel cell...